Andrieu, G. P., Shafran, J. S., Smith, C. L., Belkina, A. C., Casey, A. N., Jafari, N., & Denis, G. V. (2019). BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response. Cancer Lett.

Andrieu, Guillaume P., Jordan S. Shafran, Charlotte L. Smith, Anna C. Belkina, Allison N. Casey, Naser Jafari, and Gerald V. Denis. "BET Protein Targeting Suppresses the PD-1/PD-L1 Pathway in Triple-negative Breast Cancer and Elicits Anti-tumor Immune Response." Cancer Lett 2019.

Andrieu, Guillaume P., et al. "BET Protein Targeting Suppresses the PD-1/PD-L1 Pathway in Triple-negative Breast Cancer and Elicits Anti-tumor Immune Response." Cancer Lett 2019.